News & Perspective

Mar 20, 2012

Mar 20, 2012

Drug resistance, lack of vaccine top list of TB challenges

(CIDRAP News) – The tuberculosis toll in Europe continued a slow overall decline in 2010, but the treatment success rate for the disease is slipping as drug-resistant strains of TB grow more common, according to a report released today by the European Union (EU) and the World Health Organization (WHO).

Mar 15, 2012

Mar 15, 2012

Groups aim to increase antimicrobial stewardship

(CIDRAP News) – Infectious-disease specialty groups are teaming up to call for increased use of antimicrobial stewardship programs, saying such efforts can help preserve the effectiveness of anti-infective drugs while reducing medical costs.

Mar 12, 2012

Mar 12, 2012

Dutch export rules could block publication of Fouchier H5N1 study

(CIDRAP News) – In a new twist in the ongoing controversy over publication of two studies involving H5N1 viruses with increased transmissibility, there are indications that the Dutch government may consider using export regulations to prevent full publication of the study by Ron Fouchier, PhD, and colleagues.

Mar 09, 2012

Mar 09, 2012

CDC says flu trends still rising

(CIDRAP News) – Flu activity in the United States continued its late-season rise last week, with more respiratory specimens testing positive and more states reporting widespread activity, but flu-like illness stayed relatively low overall, the US Centers for Disease Control and Prevention (CDC) said today.

Mar 01, 2012

Mar 01, 2012

FDA clears first quadrivalent flu vaccine

(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the first quadrivalent influenza vaccine, an inhaled live attenuated influenza vaccine developed by MedImmune and modeled after its FluMist product.

The vaccine includes a second influenza B strain, which is designed to broaden protection against circulating strains. MedImmune plans to have the quadrivalent vaccine ready for the 2013-14 flu season.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»